The changing epidemiology of Asian digestive cancers: From etiologies and incidences to preventive strategies

Best Practice and Research: Clinical Gastroenterology

Volumn 29, Issue 6, 2015, Pages 843-853

  Wu, Chun Ying ^a,b,c,d,e   Lin, Jaw Town ^d,f,g  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^f FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^g I SHOU UNIVERSITY   (Taiwan)

Author keywords

Colorectal cancer; Liver cancer; Risk factor; Screening; Stomach cancer

Indexed keywords

ACETYLSALICYLIC ACID;

ASIAN; CANCER EPIDEMIOLOGY; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CHEMOPROPHYLAXIS; COLORECTAL CANCER; DIABETES MELLITUS; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; HELICOBACTER PYLORI; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEREDITY; HUMAN; LIVER CANCER; REVIEW; STOMACH CANCER; ASIA; COLORECTAL NEOPLASMS; INCIDENCE; LIVER NEOPLASMS; STOMACH NEOPLASMS;

ASIA; COLORECTAL NEOPLASMS; HUMANS; INCIDENCE; LIVER NEOPLASMS; STOMACH NEOPLASMS;

EID: 84945980533     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2015.09.016     Document Type: Review

References (86)

1. C.Y. Wu, K.N. Kuo, M.S. Wu, Y.J. Chen, C.B. Wang, and J.T. Lin Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease Gastroenterology 137 2009 1641-1648 e1-2
2. C.Y. Wu, J.T. Lin, H.J. Ho, C.W. Su, T.Y. Lee, S.Y. Wang, and et al. Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B-a nationwide cohort study Gastroenterology 147 2014 143 151 e5
3. C.Y. Wu, Y.J. Chen, H.J. Ho, Y.C. Hsu, K.N. Kuo, M.S. Wu, and et al. Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection J Am Med Assoc 308 2012 1906 1914
4. Y.C. Hsu, H.J. Ho, M.S. Wu, J.T. Lin, and C.Y. Wu The association between postoperative antiviral treatment and recurrence of hepatitis C virus-related hepatocellular carcinoma Hepatology 58 2013 150 157
5. C.Y. Wu, M.S. Wu, K.N. Kuo, C.B. Wang, Y.J. Chen, and J.T. Lin Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients J Clin Oncol 28 2010 2952 2957
6. C.C. Yeh, J.T. Lin, L.B. Jeng, H.J. Ho, H.R. Yang, M.S. Wu, and et al. Nonsteroidal anti-inflammatory drugs are associated with reduced risk of early hepatocellular carcinoma recurrence after curative liver resection: a Nationwide Cohort Study Ann Surg 261 2015 521 526
7. L.A. Torre, F. Bray, R.L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal Global cancer statistics CA Cancer J Clin 2015 65 2012 87 108
8. A. Colquhoun, M. Arnold, J. Ferlay, K.J. Goodman, D. Forman, and D.I. Soerjomataram Global patterns of cardia and non-cardia gastric cancer incidence in 2012 Gut 2015 Epub ahead of print
9. M.S. Wu, C.J. Chen, and J.T. Lin Host-environment interactions: their impact on progression from gastric inflammation to carcinogenesis and on development of new approaches to prevent and treat gastric cancer Cancer Epidemiol Biomarkers Prev 14 2005 1878 1882
10. T.T. Trang, S. Shiota, M. Matsuda, T.T. Binh, R. Suzuki, R.K. Vilaichone, and et al. The prevalence of Helicobacter pylori virulence factors in Bhutan, Vietnam, and Myanmar is related to gastric cancer incidence Biomed Res Int 2015 2015 830813
11. A.C. Ford, D. Forman, R.H. Hunt, Y. Yuan, and P. Moayyedi Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials BMJ 348 2014 g3174
12. K. Fukase, M. Kato, S. Kikuchi, K. Inoue, N. Uemura, S. Okamoto, and et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial Lancet 372 2008 392 397
13. S.B. Yoon, J.M. Park, C.H. Lim, Y.K. Cho, and M.G. Choi Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: a meta-analysis Helicobacter 19 2014 243 248
14. K.M. Fock, N. Talley, P. Moayyedi, R. Hunt, T. Azuma, K. Sugano, and et al. Asia-Pacific consensus guidelines on gastric cancer prevention J Gastroenterol Hepatol 23 2008 351 365
15. T. Shimazu, K. Wakai, A. Tamakoshi, I. Tsuji, K. Tanaka, K. Matsuo, and et al. Association of vegetable and fruit intake with gastric cancer risk among Japanese: a pooled analysis of four cohort studies Ann Oncol 25 2014 1228 1233
16. Q. Wang, Y. Chen, X. Wang, G. Gong, G. Li, and C. Li Consumption of fruit, but not vegetables, may reduce risk of gastric cancer: results from a meta-analysis of cohort studies Eur J Cancer 50 2014 1498 1509
17. Y. Guo, Z. Shan, H. Ren, and W. Chen Dairy consumption and gastric cancer risk: a meta-analysis of epidemiological studies Nutr Cancer 67 2015 555 568
18. S.B. Tian, J.C. Yu, W.M. Kang, Z.Q. Ma, X. Ye, and Z.J. Cao Association between dairy intake and gastric cancer: a meta-analysis of observational studies PLoS One 9 2014 e101728
19. L. Schwingshackl, and G. Hoffmann Adherence to Mediterranean diet and risk of cancer: a systematic review and meta-analysis of observational studies Int J Cancer 135 2014 1884 1897
20. P. Song, M. Lu, Q. Yin, L. Wu, D. Zhang, B. Fu, and et al. Red meat consumption and stomach cancer risk: a meta-analysis J Cancer Res Clin Oncol 140 2014 979 992
21. H.D. Woo, S. Park, K. Oh, H.J. Kim, H.R. Shin, H.K. Moon, and et al. Diet and cancer risk in the Korean population: a meta- analysis Asian Pac J Cancer Prev 15 2014 8509 8519
22. B. Peleteiro, C. Castro, S. Morais, A. Ferro, and N. Lunet Worldwide burden of gastric cancer attributable to tobacco smoking in 2012 and predictions for 2020 Dig Dis Sci 60 2015 2470 2476
23. S. Singh, J. Edakkanambeth Varayil, S. Devanna, M.H. Murad, and P.G. Iyer Physical activity is associated with reduced risk of gastric cancer: a systematic review and meta-analysis Cancer Prev Res (Phila) 7 2014 12 22
24. S. Mocellin, D. Verdi, K.A. Pooley, and D. Nitti Genetic variation and gastric cancer risk: a field synopsis and meta-analysis Gut 64 2015 1209 1219
25. X.L. Zhang, and Y.H. Cui GSTM1 null genotype and gastric cancer risk in the Chinese population: an updated meta-analysis and review Onco Targets Ther 8 2015 969 975
26. Z.W. Long, H.M. Yu, Y.N. Wang, D. Liu, Y.Z. Chen, Y.X. Zhao, and et al. Association of IL-17 polymorphisms with gastric cancer risk in Asian populations World J Gastroenterol 21 2015 5707 5718
27. S. Cheng, L. Wang, L. Wang, and Z. Wang Association of XRCC3 gene rs861539 polymorphism with gastric cancer risk: evidence from a case-control study and a meta-analysis Int J Clin Exp Pathol 8 2015 1911 1919
28. W. Zeng, J. Zhu, L. Shan, Z. Han, P. Aerxiding, A. Quhai, and et al. The clinicopathological significance of CDH1 in gastric cancer: a meta-analysis and systematic review Drug Des Devel Ther 9 2015 2149 2157
29. J. Zhao, Z. Zhi, G. Song, J. Wang, C. Wang, H. Ma, and et al. Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism could be a risk factor for gastric cancer Asian Pac J Cancer Prev 16 2015 2333 2340
30. Q. Ni, A. Ji, J. Yin, X. Wang, and X. Liu Effects of two common polymorphisms rs2910164 in miR-146a and rs11614913 in miR-196a2 on gastric cancer susceptibility Gastroenterol Res Pract 2015 2015 764163
31. Q. Xu, J.W. Liu, and Y. Yuan Comprehensive assessment of the association between miRNA polymorphisms and gastric cancer risk Mutat Res Rev Mutat Res 763 2015 148 160
32. S.J. Lin, J.A. Gagnon-Bartsch, I.B. Tan, S. Earle, L. Ruff, K. Pettinger, and et al. Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas Gut 2014 Epub ahead of print
33. M. Areia, R. Carvalho, A.T. Cadime, F. Rocha Goncalves, and M. Dinis-Ribeiro Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies Helicobacter 18 2013 325 337
34. Y.Y. Dan, J.B. So, and K.G. Yeoh Endoscopic screening for gastric cancer Clin Gastroenterol Hepatol 4 2006 709 716
35. M. Dinis-Ribeiro, G. Yamaki, K. Miki, A. Costa-Pereira, M. Matsukawa, and M. Kurihara Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening J Med Screen 11 2004 141 147
36. J.L. Whiting, A. Sigurdsson, D.C. Rowlands, M.T. Hallissey, and J.W. Fielding The long term results of endoscopic surveillance of premalignant gastric lesions Gut 50 2002 378 381
37. H.B. El-Serag Epidemiology of viral hepatitis and hepatocellular carcinoma Gastroenterology 142 2012 1264 1273 e1
38. L.Y. Goh, A.H. Leow, and K.L. Goh Observations on the epidemiology of gastrointestinal and liver cancers in the Asia-Pacific region J Dig Dis 15 2014 463 468
39. H.B. El-Serag, and K.L. Rudolph Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2007 2557 2576
40. G. Fattovich, F. Bortolotti, and F. Donato Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors J Hepatol 48 2008 335 352
41. C.J. Chen, H.I. Yang, J. Su, C.L. Jen, S.L. You, S.N. Lu, and et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level J Am Med Assoc 295 2006 65 73
42. G. Fattovich, T. Stroffolini, I. Zagni, and F. Donato Hepatocellular carcinoma in cirrhosis: incidence and risk factors Gastroenterology 127 2004 S35 S50
43. L.S. Qu, J.X. Liu, H.F. Zhang, J. Zhu, and C.H. Lu Effect of serum hepatitis B surface antigen levels on predicting the clinical outcomes of chronic hepatitis B infection: a meta-analysis Hepatol Res 2014 Epub ahead of print
44. C. Wang, Z. Teng, Y. Zhu, A.Z. Zhao, and C. Sun Associations between pre-S deletion mutation of hepatitis B virus and risk of hepatocellular carcinoma in the Asian population: a meta-analysis Med Sci Monit 21 2015 1072 1077
45. S. Liu, H. Zhang, C. Gu, J. Yin, Y. He, J. Xie, and et al. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis J Natl Cancer Inst 101 2009 1066 1082
46. H.P. Shi, J. Zhang, X.C. Shang, and X.Y. Xie Hepatitis B virus gene C1653T polymorphism mutation and hepatocellular carcinoma risk: an updated meta-analysis Asian Pac J Cancer Prev 14 2013 1043 1047
47. Y. Liao, X. Hu, J. Chen, B. Cai, J. Tang, B. Ying, and et al. Precore mutation of hepatitis B virus may contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis PLoS One 7 2012 e38394
48. M.H. Chang, C.J. Chen, M.S. Lai, H.M. Hsu, T.C. Wu, M.S. Kong, and et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group N Engl J Med 336 1997 1855 1859
49. M.H. Chang, W.Y. Shau, C.J. Chen, T.C. Wu, M.S. Kong, D.C. Liang, and et al. Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls J Am Med Assoc 284 2000 3040 3042
50. Y.F. Liaw, J.J. Sung, W.C. Chow, G. Farrell, C.Z. Lee, H. Yuen, and et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease N Engl J Med 351 2004 1521 1531
51. S.C. Gordon, L.E. Lamerato, L.B. Rupp, J. Li, S.D. Holmberg, A.C. Moorman, and et al. Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population Clin Gastroenterol Hepatol 12 2014 885 893
52. T. Hosaka, F. Suzuki, M. Kobayashi, Y. Seko, Y. Kawamura, H. Sezaki, and et al. Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection Hepatology 58 2013 98 107
53. T. Kumada, H. Toyoda, T. Tada, S. Kiriyama, M. Tanikawa, Y. Hisanaga, and et al. Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: a propensity score analysis J Hepatol 58 2013 427 433
54. J. Yin, N. Li, Y. Han, J. Xue, Y. Deng, J. Shi, and et al. Effect of antiviral treatment with nucleotide/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma: a two-stage longitudinal clinical study J Clin Oncol 31 2013 3647 3655
55. G. Huang, W.Y. Lau, Z.G. Wang, Z.Y. Pan, S.X. Yuan, F. Shen, and et al. Antiviral therapy improves postoperative survival in patients with hepatocellular carcinoma: a randomized controlled trial Ann Surg 261 2015 56 66
56. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics CA Cancer J Clin 2005 55 2002 74 108
57. M.L. Yu, S.M. Lin, W.L. Chuang, C.Y. Dai, J.H. Wang, S.N. Lu, and et al. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan Antivir Ther 11 2006 985 994
58. A.K. Singal, A. Singh, S. Jaganmohan, P. Guturu, R. Mummadi, Y.F. Kuo, and et al. Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis Clin Gastroenterol Hepatol 8 2010 192 199
59. R.L. Morgan, B. Baack, B.D. Smith, A. Yartel, M. Pitasi, and Y. Falck-Ytter Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies Ann Intern Med 158 2013 329 337
60. A.K. Singal, D.H.Jr. Freeman, and B.S. Anand Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma Aliment Pharmacol Ther 32 2010 851 858
61. L.Y. Cho, J.J. Yang, K.P. Ko, B. Park, A. Shin, M.K. Lim, and et al. Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: systematic review and meta-analysis Int J Cancer 128 2011 176 184
62. K. Tanaka, I. Tsuji, A. Tamakoshi, K. Matsuo, K. Wakai, C. Nagata, and et al. Diabetes mellitus and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population Jpn J Clin Oncol 44 2014 986 999
63. H.P. Chen, J.J. Shieh, C.C. Chang, T.T. Chen, J.T. Lin, M.S. Wu, and et al. Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies Gut 62 2013 606 615
64. European Association for the Study of the Liver Cancer EAFTSOTLEOFRATO. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 56 2012 908 943
65. M. Omata, L.A. Lesmana, R. Tateishi, P.J. Chen, S.M. Lin, H. Yoshida, and et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma Hepatol Int 4 2010 439 474
66. L. Bolondi, S. Sofia, S. Siringo, S. Gaiani, A. Casali, G. Zironi, and et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis Gut 48 2001 251 259
67. J.H. Wang, K.C. Chang, K.M. Kee, P.F. Chen, Y.H. Yen, P.L. Tseng, and et al. Hepatocellular carcinoma surveillance at 4- vs. 12-month intervals for patients with chronic viral hepatitis: a randomized study in community Am J Gastroenterol 108 2013 416 424
68. B.H. Zhang, B.H. Yang, and Z.Y. Tang Randomized controlled trial of screening for hepatocellular carcinoma J Cancer Res Clin Oncol 130 2004 417 422
69. C.Y. Wu, Y.C. Hsu, H.J. Ho, Y.J. Chen, T.Y. Lee, and J.T. Lin Association between ultrasonography screening and mortality in patients with hepatocellular carcinoma: a nationwide cohort study Gut 2015 Epub ahead of print
70. I. Hyodo, H. Suzuki, K. Takahashi, Y. Saito, S. Tanaka, H.M. Chiu, and et al. Present status and perspectives of colorectal cancer in Asia: Colorectal Cancer Working Group report in 30th Asia-Pacific Cancer Conference Jpn J Clin Oncol 40 Suppl. 1 2010 i38 43
71. A.A. Lertkhachonsuk, C.H. Yip, T. Khuhaprema, D.S. Chen, M. Plummer, S.H. Jee, and et al. Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013 Lancet Oncol 14 2013 e497 507
72. S. Park, H.R. Shin, B. Lee, A. Shin, K.W. Jung, D.H. Lee, and et al. Attributable fraction of alcohol consumption on cancer using population-based nationwide cancer incidence and mortality data in the Republic of Korea BMC Cancer 14 2014 420
73. N.M. Pham, T. Mizoue, K. Tanaka, I. Tsuji, A. Tamakoshi, K. Matsuo, and et al. Meat consumption and colorectal cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population Jpn J Clin Oncol 44 2014 641 650
74. W. Zhiqin, S. Palaniappan, and R.A. Raja Ali Inflammatory bowel disease-related colorectal cancer in the Asia-Pacific region: past, present, and future Intest Res 12 2014 194 204
75. M. Crosara Teixeira, M.I. Braghiroli, J. Sabbaga, and P.M. Hoff Primary prevention of colorectal cancer: myth or reality? World J Gastroenterol 20 2014 15060 15069
76. X. Ye, J. Fu, Y. Yang, and S. Chen Dose-risk and duration-risk relationships between aspirin and colorectal cancer: a meta-analysis of published cohort studies PLoS One 8 2013 e57578
77. S. Friis, A.H. Riis, R. Erichsen, J.A. Baron, and H.T. Sorensen Low-dose aspirin or nonsteroidal anti-inflammatory drug use and colorectal cancer risk: a population-based, case-control study Ann Intern Med 163 2015 347 355
78. N. Murphy, H.D. Strickler, F.Z. Stanczyk, X. Xue, S. Wassertheil-Smoller, T.E. Rohan, and et al. A prospective evaluation of endogenous sex hormone levels and colorectal cancer risk in postmenopausal women J Natl Cancer Inst 107 2015
79. K.J. Lin, W.Y. Cheung, J.Y. Lai, and E.L. Giovannucci The effect of estrogen vs. combined estrogen-progestogen therapy on the risk of colorectal cancer Int J Cancer 130 2012 419 430
80. H. Ishikawa, T. Nakamura, A. Kawano, N. Gondo, and T. Sakai Chemoprevention of colorectal cancer in Japan: a brief introduction to current clinical trials J Gastroenterol 44 Suppl. 19 2009 77 81
81. W.H. Jia, B. Zhang, K. Matsuo, A. Shin, Y.B. Xiang, S.H. Jee, and et al. Genome-wide association analyses in East Asians identify new susceptibility loci for colorectal cancer Nat Genet 45 2013 191 196
82. B. Zhang, W.H. Jia, K. Matsuda, S.S. Kweon, K. Matsuo, Y.B. Xiang, and et al. Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk Nat Genet 46 2014 533 542
83. J.J. Sung, S.C. Ng, F.K. Chan, H.M. Chiu, H.S. Kim, T. Matsuda, and et al. An updated Asia Pacific consensus recommendations on colorectal cancer screening Gut 64 2015 121 132
84. J.K. Lee, E.G. Liles, S. Bent, T.R. Levin, and D.A. Corley Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis Ann Intern Med 160 2014 171
85. S. Hundt, U. Haug, and H. Brenner Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection Ann Intern Med 150 2009 162 169
86. S. Crotta, N. Segnan, S. Paganin, B. Dagnes, R. Rosset, and C. Senore High rate of advanced adenoma detection in 4 rounds of colorectal cancer screening with the fecal immunochemical test Clin Gastroenterol Hepatol 10 2012 633 638